ReviewNanomedicine (London, England)2025
Therapeutic opportunities for nanomedicine with hollow one-dimensional silicon nanotubes.
Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
While perhaps best known for its role in the semiconductor device industry, silicon at the nanoscale is drawing extensive attention to biotech applications such as drug delivery as a consequence of structural diversity and biomedically useful properties. In this focused review we specifically center on one-dimensional nanotubes of silicon by first discussing fabrication routes and then cover fundamental studies of silicon-based nanotube structures relevant to applications in non-traditional platinate chemotherapy as well as gene therapy. Two types of basic platforms are described: (1) freestanding nanotube bundles as well as (2) patterned arrays. Our emphasis here is with regard to tunability of structure tailored to a given application. We conclude with a discussion of existing challenges and opportunities for the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.